Home > Financial Ratios > GLENMARK LIFE SCIENCES

GLENMARK LIFE SCIENCES
Core EBITDA Margin

    Back to All Ratios
GLENMARK LIFE SCIENCES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for GLENMARK LIFE SCIENCES
Please provide your vote to see the results

GLENMARK LIFE SCIENCES Last 5 Year Core EBITDA Margin History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Margin(%) 29.4429.5628.9831.2830.66

What is the latest Core EBITDA Margin ratio of GLENMARK LIFE SCIENCES ?

The latest Core EBITDA Margin ratio of GLENMARK LIFE SCIENCES is 29.44 based on Mar2024 Standalone results.
Year Core EBITDA Margin
Mar202429.44
Mar202329.56
Mar202228.98
Mar202131.28
Mar202030.66

How is Core EBITDA Margin of GLENMARK LIFE SCIENCES Trending?

Years Core EBITDA Margin % Change
Mar2024 29.44
-0.41
Mar2023 29.56
2.00
Mar2022 28.98
-7.35
Mar2021 31.28
2.02
Mar2020 30.66 -

Other Financial Ratios of GLENMARK LIFE SCIENCES


Compare Core EBITDA Margin ratio of peers of GLENMARK LIFE SCIENCES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK LIFE SCIENCES ₹13,067.1 Cr -1.6% 2.6% 74.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹422,271.0 Cr -0.9% -4.8% 50.2% Stock Analytics
DIVIS LABORATORIES ₹161,183.0 Cr 3% 5.9% 65% Stock Analytics
CIPLA ₹120,605.0 Cr 1.5% 0.1% 19.9% Stock Analytics
DR REDDYS LABORATORIES ₹100,869.0 Cr -0.4% -8.2% 7.1% Stock Analytics
ZYDUS LIFESCIENCES ₹95,808.6 Cr 0.6% -5.3% 51% Stock Analytics


GLENMARK LIFE SCIENCES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK LIFE SCIENCES

-1.6%

2.6%

74.8%

SENSEX

3.5%

-0.1%

21.9%


You may also like the below Video Courses